Cargando…
Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS—Case Report
Preeclampsia is a pregnancy-specific disorder affecting ca 3% of all pregnant women. Preeclampsia is the source of severe pregnancy complications. Later life consequences for mother and infant include increased risk of cardiovascular disease. Preeclampsia is caused by the dysfunction of the endothel...
Autores principales: | Lokki, A. Inkeri, Haapio, Mikko, Heikkinen-Eloranta, Jenni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145984/ https://www.ncbi.nlm.nih.gov/pubmed/32308654 http://dx.doi.org/10.3389/fimmu.2020.00548 |
Ejemplares similares
-
Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
por: Bouwmeester, Romy N., et al.
Publicado: (2021) -
Remission of aHUS neurological damage with eculizumab
por: Ávila, Ana, et al.
Publicado: (2015) -
Eculizumab and aHUS: Spotlight on Patient-Centered Care
por: Rafat, Cédric, et al.
Publicado: (2020) -
Can eculizumab be discontinued in aHUS?: Case report and review of the literature
por: Sahutoglu, Tuncay, et al.
Publicado: (2016) -
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
por: Rathbone, John, et al.
Publicado: (2013)